Back to Results
First PageMeta Content
Pharmacy / Pharmaceuticals policy / Pharmaceutical industry / Generic drug / Bioequivalence / Food and Drug Administration / Abbreviated New Drug Application / Therapeutic drug monitoring / Bioavailability / Pharmaceutical sciences / Pharmacology / Pharmacokinetics


Disclaimer Statement The attached package contains background information prepared by the Food and Drug Administration (FDA) for the panel members of the advisory committee. The FDA background package might contain asses
Add to Reading List

Open Document

File Size: 157,95 KB

Share Result on Facebook

City

Silver Spring / /

Country

United States / /

Facility

Food and Drug Administration Campus / IMS Institute / FDA White Oak Campus / White Oak Conference Center / /

IndustryTerm

pharmaceutical equivalence / manufacturing data / pharmaceutical quality standards / pharmaceutical products / generic drug products / drug products / generic products / pharmaceutical quality / narrow therapeutic range drug products / /

Organization

Food and Drug Administration / ACPS Committee / office of Testing Research / office of Pharmaceutical Science / IMS Institute for Healthcare Informatics / Advisory Committee for Pharmaceutical Science / Advisory Committee / Center for Drug Evaluation / Advisory Committee for Pharmaceutical Science and Clinical Pharmacology / /

Person

Helen Winkle / Yvette Waples / Helen N. Winkle / /

Position

Advisor / Director / General / Federal Official / /

Product

phenytoin / theophylline / digoxin / /

ProvinceOrState

Maryland / /

URL

http /

SocialTag